USE OF PDE III INHIBITORS AND/OR CALCIUM SENSITIZERS FOR THE TREATMENT OF ASYMPTOMATIC (OCCULT) HEART FAILURE

摘要

The invention relates to use of a phosphodiesterase type III (PDE . Ill) inhibitor or Ca 2+- sensitizing agent or a pharmaceutically acceptable derivative thereof for preparation of a medication for the prolongation of time until onset of clinical symptoms in patients having an asymptomatic (occult) heart failure or for the reduction of heart size of a patient, suffering from asymptomatic (occult) heart failure.